New Drug Candidate May Reduce Deficits in Parkinson’s Disease
Health & BehaviorAn international team led by University of California San Diego researchers has employed a novel computational approach to design and create a new compound that in laboratory studies has reduced deficits and neurodegenerative symptoms that underlie Parkinson’s disease.